search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Brainstorm Cell Therapeutics Inc.

    (NASDAQ:BCLI)

    $2.9

    $0.01

    0.35%

    Brainstorm Cell Therapeutics Inc. Chart

    BCLI Stock Price Today

    Brainstorm Cell Therapeutics Inc. (BCLI) stock rallied over 0.35% intraday to trade at $2.90 a share on NASDAQ. The stock opened with a gain of 0.35% at $2.88 and touched an intraday high of $2.93, rising 0.35% against the last close of $2.89. The stock went to a low of $2.8 during the session.

    Stock Snapshot

    $2.89

    Prev. Close

    101.04 Million

    Market Cap

    $2.8

    Day Low

    $2.88

    Open

    36.44 Million

    Number of Shares

    $2.93

    Day High

    -

    P/E ratio

    -0.64

    EPS (TTM)

    0.61

    Cash Flow per Share

    2.39

    Free Float in %

    0.69

    Book Value

    50,078

    Volume

    Brainstorm Cell Therapeutics Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$2.88$2.93$2.8$2.950,100
    2022-06-22$2.89$2.94$2.85$2.8930,000
    2022-06-21$2.86$2.95$2.78$2.9342,800
    2022-06-17$2.77$2.93$2.77$2.8939,800
    2022-06-16$2.83$2.85$2.7$2.7694,600
    2022-06-15$2.85$2.93$2.82$2.8544,400
    2022-06-14$2.88$2.93$2.84$2.8441,100
    2022-06-13$2.85$3$2.85$2.89105,200
    2022-06-10$2.92$3$2.87$2.9630,800
    2022-06-09$2.95$3.03$2.92$2.9432,800

    Contact Details

    1325 Avenue of Americas
    28th Floor
    New York, NY 10019
    United States

    Webiste:BCLI

    201 488 0460

    Company Information

    Employees-

    Beta0.1

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and in Phase II for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other central nervous system disorders. The company has a partnership with Catalent for the manufacture of NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York.

    Frequently Asked Questions

    icon

    What is the current Brainstorm Cell Therapeutics Inc. (BCLI) stock price?

    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) stock price is $2.9 as of the last check on Thursday, June 23. During the trading session, BCLI stock reached the peak price of $2.93 while $2.8 was the lowest point it dropped to.

    icon

    BCLI's industry and sector of operation?

    The NASDAQ listed BCLI is part of Biotechnology industry that operates in the broader Health Care sector. Brainstorm Cell Therapeutics Inc. , a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

    icon

    Who are the executives of BCLI?

    Mr. Chaim Lebovits
    Chief Exec. Officer
    Dr. Irit Arbel DSc, Ph.D.
    Co-Founder & Independent Vice Chair of the Board
    Dr. Ralph Z. Kern
    Pres & Chief Medical Officer
    Dr. Stacy R. Lindborg Ph.D.
    Exec. VP & Chief Devel. Officer

    icon

    What is the BCLI stock price today?

    BCLI stock traded closed the last session at $2.9, which is $0.01 or 0.35% lower than its previous close of $2.89. BCLI's current trading price is 9.43% lower than its 52-week high of $4.46 where as its distance from 52-week low of 2.65% is -34.98%.

    icon

    How many employees does BCLI have?

    Number of BCLI employees currently stands at -. BCLI operates from 1325 Avenue of Americas, 28th Floor, New York, NY 10019, United States.

    icon

    Link for BCLI official website?

    Official Webiste of $BCLI is: https://www.brainstorm-cell.com

    icon

    How do I contact BCLI?

    BCLI could be contacted at BCLI operates from 1325 Avenue of Americas, 28th Floor, New York, NY 10019, United States, or at phone #201 488 0460 and can also be accessed through its website.

    icon

    How many shares of BCLI are traded daily?

    BCLI stock volume for the day was 50,078 shares while in the previous session number of BCLI shares traded was 50,100 . The average number of BCLI shares traded daily for last 3 months was 62.49 Thousands.

    icon

    How much did BCLI change today?

    The percentage change in BCLI stock occurred in the recent session was 0.35% while the dollar amount for the price change in BCLI stock was $0.01.

    icon

    What price range BCLI stock been trading in?

    In the recent session, the day high for BCLI stock was $2.93 while the low for BCLI stock touched on the day was $2.8.

    icon

    What is the market cap of BCLI currently?

    The market value of BCLI currently stands at 101.04 Million with its latest stock price at $2.9 and 36.44 Million of its shares outstanding.